Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design. Rana NChakravarthy ABKachnic L. Curr Treat Options Oncol. 2017 Feb;18(2):13.

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. Marur S, Li S, Cmelak AJ, Gillison ML, Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, Trevarthen DR, Balkrishna J, Murphy BA, Agrawal N, Colevas AD, Chung CH, Burtness B. J Clin Oncol. 2016 Dec 28.

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, Rana NGAttia A, Gettinger SN, Contessa JN, Yu JB, Chiang VL.​ J Clin Oncol. 2017 Apr 1;35(10):1070-1077

Central liver toxicity after SBRT: An expanded analysis and predictive nomogram. Toesca DA, Osmundson EC, Eyben RV, Shaffer JL, Lu P, Koong AC, Chang DT. Radiother Oncol. 2017 Jan;122(1):130-136. 

Central Nervous System Disease, Education, and Race Impact Radiation Refusal in Pediatric Cancer Patients. Patel CGStavas M, Perkins S, Shinohara ET.  J Pediatr Hematol Oncol. 2017 Jul;39(5):382-387

Margin of error for a frameless image guided radiosurgery system: Direct confirmation based on posttreatment MRI scans. Luo G, Neimat JS, Cmelak A, Kirschner ANAttia A, Morales-Paliza MDing GX. Pract Radiat Oncol. 2017 May - Jun;7(3):e223-e231

Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone. Farris M, McTyre ER, Cramer CK, Hughes R, Randolph DM 2nd, Ayala-Peacock DN, Bourland JD, Ruiz J, Watabe K, Laxton AW, Tatter SB, Zhou X, Chan MD. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):131-141. 

Targeting Enox1 in tumor stroma increases the efficacy of fractionated radiotherapy. Smith CA, Mont S, Traver G, Sekhar KR, Crooks PA, Freeman ML. Oncotarget. 2016 Nov 22;7(47):77926-77936. 

Accumulation of isolevuglandin-modified protein in normal and fibrotic lung. Mont S, Davies SS, Roberts Second LJ, Mernaugh RL, McDonald WH, Segal BH, Zackert W, Kropski JA, Blackwell TS, Sekhar KR, Galligan JJ, Massion PP, Marnett LJ, Travis EL, Freeman ML. Sci Rep. 2016 Apr 27;6:24919.

Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial. Mesía R, Henke M, Fortin A, Minn H, Yunes Ancona AC, Cmelak A, Markowitz AB, Hotte SJ, Singh S, Chan AT, Merlano MC, Skladowski K, Zhang A, Oliner KS, VanderWalde A, Giralt J. Lancet Oncol. 2015 Feb;16(2):208-20. doi: 10.1016/S1470-2045(14)71198-2. Epub 2015 Jan 15.

Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial. Giralt J, Trigo J, Nuyts S, Ozsahin M, Skladowski K, Hatoum G, Daisne JF, Yunes Ancona AC, Cmelak A, Mesía R, Zhang A, Oliner KS, VanderWalde A. Lancet Oncol. 2015 Feb;16(2):221-32. doi: 10.1016/S1470-2045(14)71200-8. Epub 2015 Jan 15.

​Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer. Santivasi WL, Wang H, Wang T, Yang Q, Mo X, Brogi E, Haffty BG, Chakravarthy AB, Xia F. Br J Cancer. 2015 Jul 28;113(3):453-9. doi: 10.1038/bjc.2015.208. Epub 2015 Jun 9.  

Clinical Faculty

Research Faculty